Yasmeen Rahimi
Stock Analyst at Piper Sandler
(4.14)
# 818
Out of 5,182 analysts
99
Total ratings
42.42%
Success rate
19.2%
Average return
Main Sectors:
Stocks Rated by Yasmeen Rahimi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ROIV Roivant Sciences | Maintains: Overweight | $22 → $40 | $27.85 | +43.63% | 1 | Apr 16, 2026 | |
| TVRD Tvardi Therapeutics | Maintains: Neutral | $4 → $3 | $3.05 | -1.64% | 2 | Apr 1, 2026 | |
| ANAB AnaptysBio | Maintains: Overweight | $67 → $95 | $66.59 | +42.66% | 2 | Mar 31, 2026 | |
| PLRX Pliant Therapeutics | Maintains: Overweight | $4 → $3 | $1.21 | +147.93% | 3 | Mar 12, 2026 | |
| ARCT Arcturus Therapeutics Holdings | Maintains: Overweight | $72 → $25 | $8.30 | +201.20% | 3 | Mar 4, 2026 | |
| CLYM Climb Bio | Initiates: Overweight | $23 | $9.50 | +142.11% | 1 | Feb 13, 2026 | |
| KRRO Korro Bio | Upgrades: Overweight | $11 → $30 | $12.84 | +133.64% | 3 | Jan 29, 2026 | |
| PRAX Praxis Precision Medicines | Maintains: Overweight | $450 → $1,200 | $330.99 | +262.55% | 4 | Jan 28, 2026 | |
| STTK Shattuck Labs | Initiates: Overweight | $15 | $7.72 | +94.30% | 1 | Jan 28, 2026 | |
| BIOA BioAge Labs | Initiates: Overweight | $73 | $18.06 | +304.21% | 1 | Jan 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $25 | $1.96 | +1,175.51% | 1 | Dec 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $540 → $900 | $520.09 | +73.05% | 5 | Dec 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $75 | $76.39 | -1.82% | 1 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $36 | $10.79 | +233.64% | 5 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $78 | $31.81 | +145.21% | 1 | Oct 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $20 | $15.11 | +32.36% | 1 | Sep 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $26 | $5.13 | +406.82% | 1 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $93 → $145 | $52.75 | +174.88% | 2 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $51 | $30.64 | +66.45% | 4 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $10 → $6 | $1.69 | +255.03% | 2 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $48 | $14.42 | +232.87% | 1 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $93 | $90.24 | +3.06% | 1 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $75 | $9.29 | +707.32% | 1 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $105 | $86.74 | +21.06% | 1 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $37 | $30.45 | +21.51% | 2 | Sep 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $26 | $5.41 | +380.59% | 2 | Sep 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $280 | $9.98 | +2,705.61% | 3 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $97 | $38.62 | +151.17% | 4 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $76 | $28.75 | +164.35% | 1 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $25 | $2.80 | +792.86% | 3 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $30 | $12.61 | +137.91% | 1 | Jun 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $6 → $12 | $12.81 | -6.32% | 2 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $90 | $7.23 | +1,144.81% | 1 | Apr 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 | $0.35 | +4,204.16% | 1 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $16 | $5.16 | +210.08% | 2 | Mar 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $58 → $93 | $45.33 | +105.16% | 3 | Oct 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $28 → $57 | $28.62 | +99.16% | 2 | Oct 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $67 | $8.12 | +725.12% | 1 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $13 → $20 | $0.79 | +2,428.76% | 5 | Jul 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $35 | $98.51 | -64.47% | 3 | Jul 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $87 | $13.26 | +556.36% | 3 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $75 → $175 | $6.43 | +2,621.62% | 4 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $50 → $72 | $61.60 | +16.88% | 5 | Jun 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $40 | $0.70 | +5,614.29% | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $420 | $13.93 | +2,915.08% | 1 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $77 | $92.48 | -16.74% | 1 | Jul 31, 2020 |
Roivant Sciences
Apr 16, 2026
Maintains: Overweight
Price Target: $22 → $40
Current: $27.85
Upside: +43.63%
Tvardi Therapeutics
Apr 1, 2026
Maintains: Neutral
Price Target: $4 → $3
Current: $3.05
Upside: -1.64%
AnaptysBio
Mar 31, 2026
Maintains: Overweight
Price Target: $67 → $95
Current: $66.59
Upside: +42.66%
Pliant Therapeutics
Mar 12, 2026
Maintains: Overweight
Price Target: $4 → $3
Current: $1.21
Upside: +147.93%
Arcturus Therapeutics Holdings
Mar 4, 2026
Maintains: Overweight
Price Target: $72 → $25
Current: $8.30
Upside: +201.20%
Climb Bio
Feb 13, 2026
Initiates: Overweight
Price Target: $23
Current: $9.50
Upside: +142.11%
Korro Bio
Jan 29, 2026
Upgrades: Overweight
Price Target: $11 → $30
Current: $12.84
Upside: +133.64%
Praxis Precision Medicines
Jan 28, 2026
Maintains: Overweight
Price Target: $450 → $1,200
Current: $330.99
Upside: +262.55%
Shattuck Labs
Jan 28, 2026
Initiates: Overweight
Price Target: $15
Current: $7.72
Upside: +94.30%
BioAge Labs
Jan 27, 2026
Initiates: Overweight
Price Target: $73
Current: $18.06
Upside: +304.21%
Dec 29, 2025
Initiates: Overweight
Price Target: $25
Current: $1.96
Upside: +1,175.51%
Dec 19, 2025
Maintains: Overweight
Price Target: $540 → $900
Current: $520.09
Upside: +73.05%
Dec 18, 2025
Initiates: Overweight
Price Target: $75
Current: $76.39
Upside: -1.82%
Oct 28, 2025
Maintains: Overweight
Price Target: $15 → $36
Current: $10.79
Upside: +233.64%
Oct 6, 2025
Initiates: Overweight
Price Target: $78
Current: $31.81
Upside: +145.21%
Sep 8, 2025
Initiates: Overweight
Price Target: $20
Current: $15.11
Upside: +32.36%
Aug 27, 2025
Initiates: Overweight
Price Target: $26
Current: $5.13
Upside: +406.82%
Apr 24, 2025
Maintains: Overweight
Price Target: $93 → $145
Current: $52.75
Upside: +174.88%
Apr 2, 2025
Maintains: Overweight
Price Target: $51
Current: $30.64
Upside: +66.45%
Mar 7, 2025
Maintains: Overweight
Price Target: $10 → $6
Current: $1.69
Upside: +255.03%
Feb 28, 2025
Initiates: Overweight
Price Target: $48
Current: $14.42
Upside: +232.87%
Jan 23, 2025
Initiates: Overweight
Price Target: $93
Current: $90.24
Upside: +3.06%
Nov 5, 2024
Initiates: Overweight
Price Target: $75
Current: $9.29
Upside: +707.32%
Nov 4, 2024
Initiates: Overweight
Price Target: $105
Current: $86.74
Upside: +21.06%
Sep 23, 2024
Reiterates: Overweight
Price Target: $37
Current: $30.45
Upside: +21.51%
Sep 19, 2024
Maintains: Overweight
Price Target: $26
Current: $5.41
Upside: +380.59%
Jul 16, 2024
Reiterates: Overweight
Price Target: $280
Current: $9.98
Upside: +2,705.61%
Jul 2, 2024
Maintains: Overweight
Price Target: $97
Current: $38.62
Upside: +151.17%
Jun 26, 2024
Initiates: Overweight
Price Target: $76
Current: $28.75
Upside: +164.35%
Jun 21, 2024
Maintains: Overweight
Price Target: $25
Current: $2.80
Upside: +792.86%
Jun 13, 2024
Initiates: Overweight
Price Target: $30
Current: $12.61
Upside: +137.91%
May 7, 2024
Upgrades: Overweight
Price Target: $6 → $12
Current: $12.81
Upside: -6.32%
Apr 4, 2024
Initiates: Overweight
Price Target: $90
Current: $7.23
Upside: +1,144.81%
Mar 27, 2024
Maintains: Overweight
Price Target: $15
Current: $0.35
Upside: +4,204.16%
Mar 4, 2024
Maintains: Overweight
Price Target: $7 → $16
Current: $5.16
Upside: +210.08%
Oct 27, 2023
Maintains: Overweight
Price Target: $58 → $93
Current: $45.33
Upside: +105.16%
Oct 24, 2023
Maintains: Overweight
Price Target: $28 → $57
Current: $28.62
Upside: +99.16%
Aug 8, 2023
Initiates: Overweight
Price Target: $67
Current: $8.12
Upside: +725.12%
Jul 21, 2023
Maintains: Overweight
Price Target: $13 → $20
Current: $0.79
Upside: +2,428.76%
Jul 3, 2023
Reiterates: Overweight
Price Target: $35
Current: $98.51
Upside: -64.47%
Feb 8, 2023
Maintains: Overweight
Price Target: $87
Current: $13.26
Upside: +556.36%
Jan 17, 2023
Maintains: Overweight
Price Target: $75 → $175
Current: $6.43
Upside: +2,621.62%
Jun 10, 2022
Maintains: Overweight
Price Target: $50 → $72
Current: $61.60
Upside: +16.88%
Aug 24, 2021
Initiates: Overweight
Price Target: $40
Current: $0.70
Upside: +5,614.29%
Aug 26, 2020
Initiates: Overweight
Price Target: $420
Current: $13.93
Upside: +2,915.08%
Jul 31, 2020
Initiates: Overweight
Price Target: $77
Current: $92.48
Upside: -16.74%